Hybrid laser treatments may generate safer and more promising facial rejuvenation results

Fractional laser treatments for facial skin rejuvenation is an evolving field with the increase of innovative technologies. Typically, better results are achieved by using more aggressive approaches although this is accompanied by an increased risk. The demand for a modality that combines efficacy with minimal downtime and risk of adverse events led to the development of a hybrid laser, which delivers a fractional treatment of ablative CO2 and nonablative 1570 nm lasers, simultaneously. This study compares the clinical results, side effects, and downtime profile of the hybrid laser in multiple low-to-moderate-setting treatments versus a single high-setting treatment in the facial area.

Materials and Methods

This retrospective single-center study included 44 patients who underwent 1–3 treatments with the hybrid laser for facial rejuvenation between the years 2020–2022. The patients were divided into two groups based on the number of treatments they had received (Group A; single high-setting treatment, Group B; 2–3 low-to-moderate setting treatments). Three independent nontreating physicians evaluated the objective improvement by assessing the patients' standardized clinical photographs before and after the treatments, using three different scales. Treatment data, adverse events, and patients' satisfaction in each group were also reviewed.